Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeo Harada is active.

Publication


Featured researches published by Takeo Harada.


Tetrahedron Letters | 1994

One-pot sequential glycosylation: A new method for the synthesis of oligosaccharides

Haruo Yamada; Takeo Harada; Hiroshi Miyazaki; Takashi Takahashi

Abstract Sequential one-pot glycosylations among various glycosidic donors (glycosyl bromide, glycosyl trichloroimidate, glycosyl fluoride), a β-thiophenyl glycoside derivative and a α-methyl glycoside derivative have been attempted to give the corresponding trisaccharides.


Tetrahedron Letters | 2001

The synthesis of β-strand mimetic templates via regioselective 1,3-dipolar cycloaddition with vinylsulfone

Nobuhiro Fuchi; Takayuki Doi; Takeo Harada; Jan Urban; Bolong Cao; Michael Kahn; Takashi Takahashi

Abstract We have developed a practical synthetic route to constrained β-strand mimetic templates by regioselective 1,3-dipolar cycloaddition of azomethine imines with vinyl sulfone. A small library of β-strand mimetic templates was generated which include potent and selective inhibitors of serine proteases.


Bioorganic & Medicinal Chemistry | 1998

Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.

Yoshio Hayashi; Jun Katada; Yoshimi Sato; Katsuhide Igarashi; Yoshimi Takiguchi; Takeo Harada; Michiko Muramatsu; Emiko Yasuda; Isao Uno

A novel hexapeptide, H-Pro-Ser-Nva-Gly-Asp-Trp-OH 6, a specific antagonist of platelet fibrinogen receptor (GpIIb/IIIa), was discovered in a structure-activity relationship (SAR) study where the role of the N-terminal Pro moiety of an RGD-containing peptide, H-Pro-Ser-Arg-Gly-Asp-Trp-OH 1, which is a potent but not specific antagonist toward GpIIb/IIIa integrin, was investigated. This novel peptide 6 exhibits very high activity as a human platelet aggregation inhibitor (IC50 0.59 microM, human PRP/collagen) as well as marked specificity for GpIIb/IIIa. A series of substitutions at the third position (Nva residue) in this hexapeptide, focused on the conformational rigidity, led to compounds which are superior to the original novel peptide 6 with regard to anti-platelet activity. The peptides, H-Pro-Ser-Hyp-Gly-Asp-Trp-OH 17 and H-Pro-Ser-delta Pro-Gly-Asp-Trp-OH 18 with the 5-membered ring structure, which restricted the conformation of the peptide backbone at the third position, inhibited the aggregation of human platelets at submicromolar concentrations (IC50 0.39 and 0.30 microM, respectively). Further structure-activity relationship studies at each position of the peptide sequence suggest a novel motif sequence, Pro-X1-X2-X3-Asp-X4, for specific GpIIb/IIIa integrin recognition, in which the N-terminal free Pro residue and the Asp residue at the fifth position are essential to the activity. This motif sequence is summarized as follows: (1) a small amino acid such as Ser, Ala or Gly is preferable at X1 position; (2) X2 may be any amino acid, preferably a bulky amino acid such as Tle or a cyclic amino acid such as Pro; (3) X3 must be a small amino acid such as Gly; and (4) X4 is preferably an amino acid with an aromatic side chain.


ChemMedChem | 2007

Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.

Miyuki Shoda; Takeo Harada; Kazuo Yano; Florence L. Stahura; Takeshi Himeno; Satoshi Shiojiri; Yuji Kogami; Hiroyuki Kouji; Jürgen Bajorath

The binding of lymphocyte function‐associated antigen‐1 (LFA‐1) to its ligand on endothelial cells, intercellular adhesion molecule‐1 (ICAM‐1), is a crucial step in the migration of leukocytes during the early stages of inflammation and is also involved in T‐cell activation. In this paper, we report the identification of a series of novel antagonists of the LFA‐1/ICAM‐1 interaction using ligand‐based virtual screening (VS), analogue design, and structure–activity relationship (SAR) analysis. Candidate compounds were evaluated in protein binding and cell adhesion assays. Experimental evaluation of only 25 candidates selected from a pool of ∼2.5 million database compounds identified an initial hit that could be expanded and converted into a lead that effectively blocked the interaction between LFA‐1 and ICAM‐1.


Tetrahedron Letters | 1992

Synthetic approach to identification of periplaneta sex pheromones

Takeo Harada; Takashi Takahashi; Shozo Takahashi

Abstract Syntheses of the proposed structure of periplanone J ( 1 ) and its epimer 2 , and the discussion on the true structure of PJ based on the spectral study of 1,2 and the natural PJ are described.


Tetrahedron Letters | 1995

Conformational Analysis of a Branched Sugar in Aqueous Solution Based on Molecular Mechanics and 1H-NMR Studies

Haruo Yamada; Takeo Harada; Takashi Takahashi

Abstract MM2 and AMBER force fields in both vacuum and GB/SA solvation model were examined to find the most effective method for elucidating the conformational properties of the trisaccharide 2, which is essential to the elicitor activity of hexa-β-D-glucopyranosyl-D-glucitol ( 1 ). The NMR studies reveal that the combination of AMBER force field and GB/SA solvation treatment is quite effective in analyzing the conformation of oliosaccharide in water.


Natural Product Letters | 1992

Synthesis and Structure Determination of Periplanone A Based On Molecular Mechanics Calculation

Takashi Takahashi; Takeo Harada; Takayuki Doi

Abstract Reexamination of the stereoselectivity in the epoxidation of 10-membered exocyclic enone and the structure determination of periplanone A and B based on molecular mechanics calculation are described.


Archive | 2002

In vitro and in vivo properties of NSL-9511, a novel anti-platelet hexapeptide without an RGD sequence

Jun Katada; Yoshio Hayashi; Yoshimi Sato; Michiko Muramatsu; Yoshimi Takiguchi; Takeo Harada; Toshio Fujiyoshi; Isao Uno

Integrins are heterodimeric cell surface receptor molecules and are thought to be particularly important mediators of cell adhesion to extracellular matrix proteins, cell migration, cell-to-cell contact, etc. Many of them, such as platelet GpIIb/IIIa (fibrinogen receptor), vitronectin receptor and fibronectin receptor recognize the Arg-GlyAsp sequence (RGD) as a common recognition motif within their putative ligands [1,2]. Because the RGD sequence has been found in many types of proteins, there are apparent redundancies in integrin-ligand interactions. These redundancies are interesting aspects of integrin receptors and may be beneficial to cell functions. We are developing small peptides which are specific for each integrin as a tool for investigating ligand-integrin interactions and as agents for therapeutic uses. In this study, we have found a novel motif sequence which exhibited potent and highly specific GpIIb/IIIa antagonistic activity. In vivo and in vitro properties of one of these motif peptides are examined and discussed.


Journal of the American Chemical Society | 1994

Synthesis of An Elicitor-Active Hexaglucoside Analog by a One-Pot, Two-Step Glycosidation Procedure

Haruo Yamada; Takeo Harada; Takashi Takahashi


Journal of Medicinal Chemistry | 1998

GPIIb/IIIa Integrin Antagonists with the New Conformational Restriction Unit, Trisubstituted β-Amino Acid Derivatives, and a Substituted Benzamidine Structure

Yoshio Hayashi; Jun Katada; Takeo Harada; Akira Tachiki; Kiyoko Iijima; Yoshimi Takiguchi; Michiko Muramatsu; Hiroshi Miyazaki; Tohru Asari; Takeo Okazaki; Yoshimi Sato; Emiko Yasuda; Mako Yano; Isao Uno; Iwao Ojima

Collaboration


Dive into the Takeo Harada's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Haruo Yamada

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Miyazaki

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tohru Asari

Nereus Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Hirokazu Tsukamoto

Tokyo Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge